Vulval premalignant lesions: a review article

키워드

참고문헌 (94)

1. Preti M, "Squamous vulvar intraepithelial neoplasia", Clin Obstet Gynecol, 48, pp.845~861 (2005)
2. "New nomenclature for vulvar disease", Obstet Gynecol, 47, pp.122~124 (1976)
3. Wilkinson EJ, "Report of the ISSVD terminology committee", J Reprod Med, 31, pp.973~974 (1986)
4. Sideri M, "Squamous vulvar intraepithelial neoplasia : 2004 modified terminology, ISSVD Vulvar Oncology Subcommittee", J Reprod Med, 50, pp.807~810 (2005)
5. Scurry J, "Review of terminology of precursors of vulvar squamous cell carcinoma", J Low Genit Tract Dis, 10, pp.161~169 (2006)
6. Wilkinson EJ, "Pathology and genetics of tumours of the breast and female genital organs World Health Organization classification of tumours", pp.313~334 (2003), IARC Press
7. Giuliano AR, "Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions", Vaccine, 26(Suppl 10), pp.K17~K28 (2008)
8. van de Nieuwenhof HP, "Vulvar squamous cell carcinoma development after diagnosis of VIN increases with age", Eur J Cancer, 45, pp.851~856 (2009)
9. Hart WR, "Vulvar intraepithelial neoplasia : historical aspects and current status", Int J Gynecol Pathol, 20, pp.16~30 (2001)
10. Scurry J, "Pathologic audit of 164 consecutive cases of vulvar intraepithelial neoplasia", Int J Gynecol Pathol, 25, pp.176~181 (2006)
11. Yang B, "Vulvar intraepithelial neoplasia of the simplex(differentiated)type : a clinicopathologic study including analysis of HPV and p53 expression", Am J Surg Pathol, 24, pp.429~441 (2000)
12. Darragh TM, "The lower anogenital squamous terminology standardization project for HPV-associated lesions : background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology", J Low Genit Tract Dis, 16, pp.205~242 (2012)
13. "International classification of diseases for mortality and morbidity statistics (11th revision)" (2018)[URL]
14. Bornstein J, "The 2015 International Society for the Study of Vulvovaginal Disease(ISSVD)terminology of vulvar squamous intraepithelial lesions", J Low Genit Tract Dis, 20, pp.11~14 (2016)
15. Crum C, "WHO classification of tumours of female reproductive organs", pp.229~252 (2014), IARC Press
16. "Female genital tumours" (2020)[URL]
17. Lebreton M, "Vulvar intraepithelial neoplasia : classification, epidemiology, diagnosis, and management", J Gynecol Obstet Hum Reprod, 49, pp.101801~ (2020)
18. Lukasiewicz E, "Incidence and management of condylomata acuminata by French general physicians", Ann Dermatol Venereol, 129, pp.991~996 (2002)
19. Monsonégo J, "Anogenital warts incidence, medical management and costs in women consulting gynaecologists in France", Gynecol Obstet Fertil, 35, pp.107~113 (2007)
20. van Seters M, "Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients", Gynecol Oncol, 97, pp.645~651 (2005)
21. Jones RW, "Vulvar intraepithelial neoplasia : aspects of the natural history and outcome in 405 women", Obstet Gynecol, 106, pp.1319~1326 (2005)
22. Thuijs NB, "Vulvar intraepithelial neoplasia : incidence and long-term risk of vulvar squamous cell carcinoma", Int J Cancer, 148, pp.90~98 (2021)
23. de Sanjosé S, "Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva", Eur J Cancer, 49, pp.3450~3461 (2013)
24. Clifford GM, "A meta-analysis of anal cancer incidence by risk group : toward a unified anal cancer risk scale", Int J Cancer, 148, pp.38~47 (2021)
25. Saleem AM, "Risk of anal cancer in a cohort with human papillomavirus-related gynecologic neoplasm", Obstet Gynecol, 117, pp.643~649 (2011)
26. Faber MT, "Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva", Int J Cancer, 141, pp.1161~1169 (2017)
27. Rakislova N, "Role of human papillomavirus in vulvar cancer", Adv Anat Pathol, 24, pp.201~214 (2017)
28. Thuijs NB, "DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia", Int J Cancer, 148, pp.2481~2488 (2021)
29. Swarts DRA, "Molecular heterogeneity in human papillomavirus-dependent and-independent vulvar carcinogenesis", Cancer Med, 7, pp.4542~4553 (2018)
30. Bleeker MC, "Lichen sclerosus : incidence and risk of vulvar squamous cell carcinoma", Cancer Epidemiol Biomarkers Prev, 25, pp.1224~1230 (2016)
31. Del Pino M, "Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma", Histopathology, 62, pp.161~175 (2013)
32. Nooij LS, "Genomic characterization of vulvar(pre)cancers identifies distinct molecular subtypes with prognostic significance", Clin Cancer Res, 23, pp.6781~6789 (2017)
33. Watkins JC, "Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA", Mod Pathol, 30, pp.448~458 (2017)
34. Tessier-Cloutier B, "Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status", Mod Pathol, 33, pp.1595~1605 (2020)
35. Fatalska A, "Inflammatory proteins HMGA2 and PRTN3 as drivers of vulvar squamous cell carcinoma progression", Cancers(Basel), 13, pp.27~ (2020)
36. Hoang LN, "Squamous precursor lesions of the vulva : current classification and diagnostic challenges", Pathology, 48, pp.291~302 (2016)
37. Regauer S, "Vulvar cancers in women with vulvar lichen planus : a clinicopathological study", J Am Acad Dermatol, 71, pp.698~707 (2014)
38. McNally OM, "VIN 3 : a clinicopathologic review", Int J Gynecol Cancer, 12, pp.490~495 (2002)
39. van de Nieuwenhof HP, "Review of squamous premalignant vulvar lesions", Crit Rev Oncol Hematol, 68, pp.131~156 (2008)
40. Khan AM, "Smoking and multicentric vulval intraepithelial neoplasia", J Obstet Gynaecol, 29, pp.123~125 (2009)
41. van Beurden M, "Normal findings in vulvar examination and vulvoscopy", Br J Obstet Gynaecol, 104, pp.320~324 (1997)
42. Albuquerque A, "Recommendations favoring anal cytology as a method for anal cancer screening : a systematic review", Cancers(Basel), 11, pp.1942~ (2019)
43. Preti M, "Vulvar intraepithelial neoplasia", Best Pract Res Clin Obstet Gynaecol, 28, pp.1051~1062 (2014)
44. Jin C, "Differentiated vulvar intraepithelial neoplasia : a brief review of clinicopathologic features", Arch Pathol Lab Med, 143, pp.768~771 (2019)
45. Kesic, V., "EAGC course book of colposcopy", pp.126~163 (2004), Nova Biomedical
46. Neill S, "Ridley's the vulva" (2009), John Wiley & Sons
47. Heller DS, "Diagnostic criteria for differentiated vulvar intraepithelial neoplasia and vulvar aberrant maturation", J Low Genit Tract Dis, 25, pp.57~70 (2021)
48. Day T, "Clinicopathologic diagnostic criteria for vulvar lichen planus", J Low Genit Tract Dis, 24, pp.317~329 (2020)
49. Terlou A, "Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia", Int J Cancer, 127, pp.2831~2840 (2010)
50. van Seters M, "Disturbed patterns of immunocompetent cells in usual-type vulvar intraepithelial neoplasia", Cancer Res, 68, pp.6617~6622 (2008)
51. van Esch EM, "Intraepithelial macrophage infiltration is related to a high number of regulatory T cells and promotes a progressive course of HPVinduced vulvar neoplasia", Int J Cancer, 136, pp.E85~E94 (2015)
52. Uyttenhove C, "Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2, 3-dioxygenase", Nat Med, 9, pp.1269~1274 (2003)
53. Abdulrahman Z, "The immune microenvironment in vulvar(pre)cancer : review of literature and implications for immunotherapy", Expert Opin Biol Ther, 18, pp.1223~1233 (2018)
54. Lawrie TA, "Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia", Cochrane Database Syst Rev, 2016, pp.CD011837~ (2016)
55. Chin S, "Association of topical corticosteroids with reduced vulvar squamous cell carcinoma recurrence in patients with vulvar lichen sclerosus", JAMA Dermatol, 156, pp.813~814 (2020)
56. Te Grootenhuis NC, "Prognostic factors for local recurrence of squamous cell carcinoma of the vulva : a systematic review", Gynecol Oncol, 148, pp.622~631 (2018)
57. Yap JK, "Adjacent lichen sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma", Gynecol Oncol, 142, pp.420~426 (2016)
58. Lee A, "Long-term management of adult vulvar lichen sclerosus : a prospective cohort study of 507 women", JAMA Dermatol, 151, pp.1061~1067 (2015)
59. Bigby SM, "The natural history of vulvar intraepithelial neoplasia, differentiated type : evidence for progression and diagnostic challenges", Int J Gynecol Pathol, 35, pp.574~584 (2016)
60. Regauer S, "Residual anogenital lichen sclerosus after cancer surgery has a high risk for recurrence : a clinicopathological study of 75 women", Gynecol Oncol, 123, pp.289~294 (2011)
61. Athavale R, "Vulvar intraepithelial neoplasia--the need for auditable measures of management", Eur J Obstet Gynecol Reprod Biol, 137, pp.97~102 (2008)
62. Bradbury M, "Vulvar intraepithelial neoplasia : clinical presentation, management and outcomes in women infected with HIV", AIDS, 30, pp.859~868 (2016)
63. Bruchim I, "HPV-related vulvar intraepithelial neoplasia : outcome of different management modalities", Int J Gynaecol Obstet, 99, pp.23~27 (2007)
64. Fehr MK, "Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia", J Gynecol Oncol, 24, pp.236~241 (2013)
65. Frega A, "The re-infection rate of highrisk HPV and the recurrence rate of vulvar intraepithelial neoplasia(VIN)usual type after surgical treatment", Med Sci Monit, 17, pp.CR532~CR535 (2011)
66. Leufflen L, "Treatment of vulvar intraepithelial neoplasia with CO(2)laser vaporization and excision surgery", J Low Genit Tract Dis, 17, pp.446~451 (2013)
67. van Esch EM, "Clinical characteristics associated with development of recurrence and progression in usualtype vulvar intraepithelial neoplasia", Int J Gynecol Cancer, 23, pp.1476~1483 (2013)
68. Wallbillich JJ, "Vulvar intraepithelial neoplasia(VIN 2", 3) : comparing clinical outcomes and evaluating risk factors for recurrence, 2012, pp.127, 312~315
69. Miller BE, "Vulvar intraepithelial neoplasia treated with cavitational ultrasonic surgical aspiration", Gynecol Oncol, 85, pp.114~118 (2002)
70. De Witte CJ, "Imiquimod in cervical, vaginal and vulvar intraepithelial neoplasia : a review", Gynecol Oncol, 139, pp.377~384 (2015)
71. van Seters M, "Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2", 3. Results of a pilot study, 2002, pp.47, 701~705
72. Mathiesen O, "Topical imiquimod can reverse vulvar intraepithelial neoplasia : a randomised, double-blinded study", Gynecol Oncol, 107, pp.219~222 (2007)
73. van Seters M, "Treatment of vulvar intraepithelial neoplasia with topical imiquimod", N Engl J Med, 358, pp.1465~1473 (2008)
74. Tristram A, "Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia(RT3VIN) : a multicentre, open-label, randomised, phase 2 trial", Lancet Oncol, 15, pp.1361~1368 (2014)
75. Hurt CN, "Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod : results from a multicentre, randomised, phase II trial(RT-3VIN)", BJOG, 125, pp.1171~1177 (2018)
76. Jones SEF, "Human papillomavirus DNA methylation predicts response to treatment using cidofovir and imiquimod in vulval intraepithelial neoplasia 3", Clin Cancer Res, 23, pp.5460~5468 (2017)
77. Westermann C, "Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream", Int J Gynaecol Obstet, 120, pp.266~270 (2013)
78. Le T, "Final results of a phase 2 study using continuous 5% imiquimod cream application in the primary treatment of high-grade vulva intraepithelial neoplasia", Gynecol Oncol, 106, pp.579~584 (2007)
79. Fehr MK, "Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5-aminolevulinic acid", Lasers Surg Med, 30, pp.273~279 (2002)
80. Zawislak A, "Clinical and immunohistochemical assessment of vulval intraepithelial neoplasia following photodynamic therapy using a novel bioadhesive patch-type system loaded with 5-aminolevulinic acid", Photodiagnosis Photodyn Ther, 6, pp.28~40 (2009)
81. Buchanan TR, "Risk of cervical and vaginal dysplasia after surgery for vulvar intraepithelial neoplasia or cancer : a 6 year follow-up study", Gynecol Oncol, 155, pp.88~92 (2019)
82. Ait Menguellet S, "Management of multicentric lesions of the lower genital tract", Eur J Obstet Gynecol Reprod Biol, 132, pp.116~120 (2007)
83. Garland SM, "Human papillomavirus genotypes from vaginal and vulvar intraepithelial neoplasia in females 15-26 years of age", Obstet Gynecol, 132, pp.261~270 (2018)
84. Giuliano AR, "Nine-valent HPV vaccine efficacy against related diseases and definitive therapy : comparison with historic placebo population", Gynecol Oncol, 154, pp.110~117 (2019)
85. Joura EA, "Efficacy of a quadrivalent prophylactic human papillomavirus(types 6, 11, 16, and 18)L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions : a combined analysis of three randomised clinical trials", Lancet, 369, pp.1693~1702 (2007)
86. Micheletti L, "Vulvar lichen sclerosus and neoplastic transformation : a retrospective study of 976 cases", J Low Genit Tract Dis, 20, pp.180~183 (2016)
87. Corazza M, "Risk of vulvar carcinoma in women affected with lichen sclerosus : results of a cohort study", J Dtsch Dermatol Ges, 17, pp.1069~1071 (2019)
88. Brickman C, "Human papillomavirus in the HIV-infected host : epidemiology and pathogenesis in the antiretroviral era", Curr HIV, 2015, pp.12, 6~15
89. Konopnicki D, "HPV and HIV coinfection : a complex interaction resulting in epidemiological, clinical and therapeutic implications", Future Virol, 8, pp.903~915 (2013)
90. Reinholdt K, "Human papillomavirusrelated anogenital premalignancies and cancer in renal transplant recipients : a Danish nationwide, registrybased cohort study", Int J Cancer, 146, pp.2413~2422 (2020)
91. Preti M, "Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women", Infect Agent Cancer, 15, pp.20~ (2020)
92. Meeuwis KA, "Anogenital malignancies in women after renal transplantation over 40 years in a single center", Transplantation, 93, pp.914~922 (2012)
93. Chin-Hong PV, "Human papillomavirus in kidney transplant recipients", Semin Nephrol, 36, pp.397~404 (2016)
94. Chin-Hong PV, "Human papillomavirus infection in solid organ transplant recipients : guidelines from the American Society of Transplantation infectious diseases community of practice", Clin Transplant, 33, pp.e13590~ (2019)

관련 논문AI추천